Aurinia Pharmaceuticals Inc [NASDAQ: AUPH] stock went on a downward path that fall over -0.58% on Thursday, amounting to a one-week price increase of more than 6.16%. Over the last 12 months, AUPH stock dropped by -55.35%. The one-year Aurinia Pharmaceuticals Inc stock forecast points
Aurinia Pharmaceuticals Inc [NASDAQ: AUPH] closed the trading session at $5.74. The company report on February 15, 2024 at 6:00 AM that Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value. Total net revenue was $45.1 million and
Aurinia Pharmaceuticals Inc [NASDAQ: AUPH] loss -24.47% or -1.95 points to close at $6.02 with a heavy trading volume of 19606622 shares. The company report on February 15, 2024 at 6:00 AM that Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused
© 2024, Powered by Smart TechOne
